HUMAN GENOME SCIENCES INC Costs and Expenses
HUMAN GENOME SCIENCES INC reported Costs and Expenses of $135.53 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC costs and expenses for the quarter ending 2012-06-30 was $135.53M, a 45.18% increase year-over-year.
- HUMAN GENOME SCIENCES INC costs and expenses for the quarter ending 2012-03-31 was $123.31M, a 13.51% decline year-over-year.
- HUMAN GENOME SCIENCES INC costs and expenses for the quarter ending 2011-12-31 was $114.59M, a 17.59% increase year-over-year.
- HUMAN GENOME SCIENCES INC costs and expenses for the quarter ending 2011-09-30 was $110.02M, a 36.48% increase year-over-year.
- HUMAN GENOME SCIENCES INC costs and expenses for fiscal 2011 was $460.53M, a 32.29% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC costs and expenses for fiscal 2010 was $348.12M, a 29.14% increase from fiscal 2009.
- HUMAN GENOME SCIENCES INC costs and expenses for fiscal 2009 was $269.56M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2012-06-30 | $135.53M 10-Q · filed 2012-07-26 | $258.84M 10-Q · filed 2012-07-26 | $373.43M derived: sum of 3 quarters · filed 2012-07-26 | $483.45M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $123.31M 10-Q · filed 2012-04-26 | $237.90M derived: sum of 2 quarters · filed 2012-04-26 | $347.92M derived: sum of 3 quarters · filed 2012-04-26 | $441.27M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $114.59M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $224.60M derived: sum of 2 quarters · filed 2012-02-28 | $317.95M derived: sum of 3 quarters · filed 2012-07-26 | $460.53M 10-K · filed 2012-02-28 |
| 2011-09-30 | $110.02M 10-Q · filed 2011-10-28 | $203.37M derived: sum of 2 quarters · filed 2012-07-26 | $345.94M 10-Q · filed 2011-10-28 | $443.38M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $93.35M 10-Q · filed 2012-07-26 | $235.92M 10-Q · filed 2012-07-26 | $333.37M derived: sum of 3 quarters · filed 2012-07-26 | $413.98M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $142.57M 10-Q · filed 2012-04-26 | $240.02M derived: sum of 2 quarters · filed 2012-04-26 | $320.62M derived: sum of 3 quarters · filed 2012-04-26 | $406.41M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $97.44M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $178.05M derived: sum of 2 quarters · filed 2012-02-28 | $263.84M derived: sum of 3 quarters · filed 2012-02-28 | $348.12M 10-K · filed 2012-02-28 |
| 2010-09-30 | $80.61M 10-Q · filed 2011-10-28 | $166.39M derived: sum of 2 quarters · filed 2011-10-28 | $250.68M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $85.78M 10-Q · filed 2011-07-28 | $170.07M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $84.29M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $269.56M 10-K · filed 2012-02-28 |